Structure–Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure–Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Journal of Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2023-02-04
DOI
10.1021/acs.jmedchem.2c01647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery?
- (2022) Zhen Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
- (2022) Rong Yao et al. Microbiology Spectrum
- Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
- (2022) Mohammad Javad Nasiri et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis Drug Discovery: Challenges and New Horizons
- (2022) Guilherme F. S. Fernandes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-tuberculosis treatment strategies and drug development: challenges and priorities
- (2022) Véronique A. Dartois et al. NATURE REVIEWS MICROBIOLOGY
- Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors
- (2022) Cong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
- (2022) Osvaldo Burastero et al. JOURNAL OF MEDICINAL CHEMISTRY
- MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
- (2022) Mohd. Imran et al. Biomedicines
- Pyrimidine derivatives with antitubercular activity
- (2022) Vladimir Finger et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pretomanid for tuberculosis: a systematic review
- (2021) Tinne Gils et al. CLINICAL MICROBIOLOGY AND INFECTION
- Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
- (2021) Ju Sang Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
- (2021) Xia Yu et al. Infection and Drug Resistance
- OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
- (2020) Norimitsu Hariguchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline
- (2020) Hui Guo et al. NATURE
- 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
- (2019) Hamish S. Sutherland et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK)
- (2019) Xiaotian Kong et al. JOURNAL OF MEDICINAL CHEMISTRY
- In vitro activity of PBTZ169 against multiple Mycobacterium species
- (2018) Jin Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents
- (2018) Pingxian Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions
- (2017) Tiansheng Wang et al. ACS Medicinal Chemistry Letters
- Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
- (2013) Thomas H. Marsilje et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now